KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Pacira BioSciences (PCRX) over the last 17 years, with Q3 2025 value amounting to 0.56.

  • Pacira BioSciences' Equity Ratio rose 1377.21% to 0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year increase of 1377.21%. This contributed to the annual value of 0.5 for FY2024, which is 934.64% down from last year.
  • Pacira BioSciences' Equity Ratio amounted to 0.56 in Q3 2025, which was up 1377.21% from 0.49 recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Equity Ratio registered a high of 0.56 during Q1 2024, and its lowest value of 0.35 during Q4 2021.
  • In the last 5 years, Pacira BioSciences' Equity Ratio had a median value of 0.5 in 2023 and averaged 0.49.
  • As far as peak fluctuations go, Pacira BioSciences' Equity Ratio crashed by 2761.56% in 2021, and later surged by 3439.01% in 2023.
  • Quarter analysis of 5 years shows Pacira BioSciences' Equity Ratio stood at 0.35 in 2021, then soared by 30.98% to 0.46 in 2022, then grew by 19.89% to 0.55 in 2023, then decreased by 9.35% to 0.5 in 2024, then increased by 11.86% to 0.56 in 2025.
  • Its last three reported values are 0.56 in Q3 2025, 0.49 for Q2 2025, and 0.5 during Q1 2025.